Scientific Program

23 February 2018

As of 6 Dec 2017

The 13th International Conference of the Asian Clinical Oncology Society (ACOS 2018)
23-25 February 2018 Chiang Mai, Thailand

Friday 23 February 2018
8.30-9.00 Opening Ceremony
9.00-09.45 Keynote lecture 1
Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies
09.45-10.15 Coffee Break/ Exhibition/ Poster Session
10.15-11.00 Plenary Session 1
What is new in colorectal cancer treatment?
11.00-12.00 Industry Supported Symposium 1
Roche
“The state of art in high-risk early breast cancer patient management”
12.00-12.15 Intermission
12.15-13.00 Industry Supported Symposium 2
Pfizer
“Evaluating the role of palbociclib in HR+ HER2- metastatic breast cancer: latest evidence and clinical considerations”
13.15-14.00 Keynote lecture 2
Treatment of HCC in 2018
14.00-15.00

Invited Session 1
Colorectal

GenomicMolecular Landscape in Colorectal Cancer

  • Pathologist Perspective
  • Surgical Oncologist Perspective
  • Medical Oncologist Perspective
Invited Session 2 Breast

Optimal treatment of Metastatic Breast Cancer

  • Hormonal Positive
  • Triple Negative
  • Her-2 Positive
Invited Session 3
Cancer screening and prevention

  • Technical Details of EBUS
  • Lung Cancer Screening
  • Tobacco Cessation
Invited Session 4
GU

Multidisciplinary Management of Muscle-Invasive Bladder Cancer

  • Urologist Perspective
  • Medical Oncologist Perspective
  • Radiation Oncologist Perspective
15.00-15.30 Coffee Break/ Exhibition/ Poster Session
15.30-16.30 Invited Session 5
Bone Sarcoma

  • Systemic therapy in Osteosarcoma
  • Germline and samotic genetics of osteosarcoma
  •  Precision treatment in osteosarcoma
Invited Session 6
Non Colorectal

Update Guideline and Management for gastric cancer in Asia

  • Surgical Perspective
  • Medical Oncology Perspective: West and East Debate and Guideline Update
Invited Session 7
Thyroid

Treatment strategies for radioactive iodinerefractory, progressive differentiated thyroid cancer

  • Nuclear Medicine Perspective
  • Medical Oncology Perspective
  • Supportive Care and Management of Side Effects of Targeted Therapy in a Thyroid Cancer
Invited Session 8
GU

Prostate cancer

  • Role of MP MRI in Prostate:
  • Stateofart in sequencing treatment of metastatic castration refractory prostate cancer
16.30-17.15 Industry Supported Symposium 3
18.00-20.00 Faculty Dinner (By Invitation Only)

Remark
Symposium time will be referred to the sponsor package benefit
60 minutes
45 minutes
45 minutes
45 minutes

24 February 2018

As of 6 Dec 2017

The 13th International Conference of the Asian Clinical Oncology Society (ACOS 2018)
23-25 February 2018 Chiang Mai, Thailand

Saturday 24 February 2018
07.30-08.15 Industry Supported Symposium 4
Eli Lilly
08.15-09.00 Plenary Session 2
Breast Cancer 2018: De-escalation of adjuvant systemic therapy for breast cancer
09.00-09.45 Coffee Break/ Exhibition/ Poster Session (Tea symposium: Amgen)
“Optimization of bone health management from early to metastatic breast cancer with RANKL inhibitor”
09.45-10.30 Keynote lecture 3
New stage of the Companion Diagnostics for Lung Cancer
10.30-11.30 Invited Session 9
Pancreas

Multidisciplinary approach for locally advance pancreatic head cancer

Invited Session 10
Head and Neck

  • Advanced surgery for head and neck cancer
  •  Expanding systemic treatment opportunities in Head and neck cancers
Invited Session 11
Gyne

Metastasis to Gynecologic Tract: How to Specify Primary Site?

Case Discussion :

  • Gynecologist Perspective
  • Pathologist Perspective
  • Radiologist Perspective
Invited Session 12
Immunotherapy

  • Does immunotherapy cure advanced cancer?
  •  Predictive biomarkers for immunotherapy
  • Practical management of toxicities of immunotherapy
11.30-12.30 Industry Supported Symposium 5
TTY Biopharm
“Microsatellite Instability in Colorectal Cancer Adjuvant Therapy”

12.30-12.45 Intermission
12.45-13.30 Industry Supported Symposium 6
Astrazeneca
“PARP inhibition: Strategic approaching for BRCAm Ovarian Cancer”
13.45-14.45 Invited Session 13
Breast

  • Immunotherapy in Breast Cancer
  • Genomic Rearrangement in Breast Cancer
  • Emerging Research Strategies in Breast Cancer
Invited Session 14
Soft Tissue Sarcoma & GIST

  • Management of GIST
  • Systemic treatment of Soft Tissue Sarcoma
  • Surgical Management of soft tissue sarcoma
Invited Session 15
Gyne

Chemotherapy in gynecologic cancerAsian view

  • Endometrial cancer
  • Ovarian cancer
  • Cervical cancer
Invited Session 16
Pharmaco

  • Genetic Polymorphisms of Relevance to Management of East Asians with Cancer
  • Accessibility of High Cost Drug in Asia
  • Meeting social Economic demand Through Industry Sponsored Research
14.45-15.15 Coffee Break/ Exhibition/ Poster Session
14.45-17.00 ACOS BOARD MEETING (INVITATION ONLY)
15.15-16.15 Abstract
Session 1
Abstract
Session 2
Abstract
Session 3
Abstract
Session 4
16.15-17.15 Invited Session 17
Imaging

PET in Oncology

  • New Paradigm of PET Study in Oncology
  • Experience of PET at CMU
Invited Session 18
Supportive care

Symptom control in cancer patients

  • Dyspnea treatment
  • Pain management
  • Alternative medicinerole of acupuncture
Invited Session 19
Lung

  • Adjuvant EGFR in Lung cancer
  • Management of N2 disease
  • Role of Proton Therapy in Lung Cancer
Invited Session 20
HCC

Case discussion:  Multidisciplinary approach for HCC

Liver Surgical Perspective

  • Intervention Radiologist Perspective
  • Radiation Therapist Perspective
  • Medical Oncologist Perspective

 

17.15-18.00 Industry Supported Symposium 7
19.00-21.00 Gala Dinner


Remark
Symposium time will be referred to the sponsor package benefit
60 minutes
45 minutes
45 minutes
45 minutes

25 February 2018

As of 6 Dec 2017

The 13th International Conference of the Asian Clinical Oncology Society (ACOS 2018)
23-25 February 2018 Chiang Mai, Thailand

Sunday 25 February 2018
07.45-08.30 Industry Supported Symposium 8: MSD
Breakthrough in Solid Tumors with Immunotherapy
08.30-09.30 Invited Session 21
Lung

  • VATS for Lung Cancer
  • Mediastinal Germ Cell
  • Thymic Carcinoma
Invited Session 22
Colorectal

Case Discussion

  • Colorectal Cancer with Lung Metastasis
  • Colorectal Cancer with Liver Metastasis
Invited Session 23
NET

  • Pathological diagnosis of Neuroendocrine CA Lung
  • Treatment of SCLC
  • Treatment of Large cell Neuroendocrine CA
Invited Session 24
Colorectal

Multidisciplinary approach for locally advanced rectal cancer

  • Surgical Perspective
  • Medical Oncologist Perspective
  • Radiation Oncologist Perspectives
09.30-10.15 Plenary Session 3
Personalized, genotype-directed therapy for advanced non-small cell lung cancer
10.15-10.45 Coffee Break/ Exhibition/ Poster Session
10.45-11.45 Abstract & Poster Discussion Abstract & Poster Discussion
11.45-12.45 Industry Supported Symposium 9: MSD
Moving the Boundaries of Cancer Treatment with Immuno-Oncology
13.00-14.00 Keynote lecture 4:
Soft tissue Sarcoma
14.00-15.00 Invited Session 25
Lung

Metastatic Lung Cancer

  • Targeted Therapy in Advanced NSLC (EGFR)
  • Targeted Therapy in Advanced NSCLC (ALK & ROS 1)
  • Immunotherapy in Lung CA
Invited Session 26
Breast

  • Treatment of young women with breast cancer
  • Breast Reconstruction
Invited Session 27
Imaging

  • Lung Cancer Classification, histology versus genomics 
  • Management of Lung Squamous Cell Carcinoma 
  • Tumor Mutation Load as Predictive Marker for cancer Immunotherapy
Invited Session 28
Non Colorectal

Multidisciplinary approach for locally advanced gastric cancer

  • Molecular Genetic Study and Biomarker in Asia and Integrative Management of Locally Advanced Stage
  • Surgical Perspective
  • Conversion Surgery Perspective  
  • Multimodality Treatment Aspect for Advance Gastric Cancer in Thailand
15.00 Adjourn


Remark
Symposium time will be referred to the sponsor package benefit
60 minutes
45 minutes
45 minutes
45 minutes

Highlight topics

• Immunotherapy
• Targeted Therapies
• Biomarker
• Molecular pathology
• Precision Medicine